keyword
https://read.qxmd.com/read/37864211/extracellular-vesicles-of-the-probiotic-bacteria-e-coli-o83-activate-innate-immunity-and-prevent-allergy-in-mice
#21
JOURNAL ARTICLE
Anna Marlene Schmid, Agnieszka Razim, Magdalena Wysmołek, Daniela Kerekes, Melissa Haunstetter, Paul Kohl, Georgii Brazhnikov, Nora Geissler, Michael Thaler, Eliška Krčmářová, Martin Šindelář, Tamara Weinmayer, Jiří Hrdý, Katy Schmidt, Peter Nejsum, Bradley Whitehead, Johan Palmfeldt, Stefan Schild, Aleksandra Inić-Kanada, Ursula Wiedermann, Irma Schabussova
BACKGROUND: E. coli O83 (Colinfant Newborn) is a Gram-negative (G-) probiotic bacterium used in the clinic. When administered orally, it reduces allergic sensitisation but not allergic asthma. Intranasal administration offers a non-invasive and convenient delivery method. This route bypasses the gastrointestinal tract and provides direct access to the airways, which are the target of asthma prevention. G- bacteria such as E. coli O83 release outer membrane vesicles (OMVs) to communicate with the environment...
October 20, 2023: Cell Communication and Signaling: CCS
https://read.qxmd.com/read/37841931/a-review-of-the-pathophysiology-and-the-role-of-ion-channels-on-bronchial-asthma
#22
REVIEW
Indyra Alencar Duarte Figueiredo, Sarah Rebeca Dantas Ferreira, Jayne Muniz Fernandes, Bagnólia Araújo da Silva, Luiz Henrique César Vasconcelos, Fabiana de Andrade Cavalcante
Asthma is one of the main non-communicable chronic diseases and affects a huge portion of the population. It is a multifactorial disease, classified into several phenotypes, being the allergic the most frequent. The pathophysiological mechanism of asthma involves a Th2-type immune response, with high concentrations of allergen-specific immunoglobulin E, eosinophilia, hyperreactivity and airway remodeling. These mechanisms are orchestrated by intracellular signaling from effector cells, such as lymphocytes and eosinophils...
2023: Frontiers in Pharmacology
https://read.qxmd.com/read/37604132/increased-breath-naphthalene-in-children-with-asthma-and-wheeze-of-the-all-age-asthma-cohort-alliance
#23
JOURNAL ARTICLE
Pedram Shahrokny, Nicole Maison, Lennart Riemann, Maximilian Ehrmann, David DeLuca, Sven Schuchardt, Dominik Thiele, Markus Weckmann, Anna-Maria Dittrich, Bianca Schaub, Folke Brinkmann, Gesine Hansen, Matthias Kopp, Erika von Mutius, Klaus Rabe, Thomas Bahmer, Jens Hohlfeld, Ruth Grychtol, Olaf Holz
Background
Exhaled breath contains numerous volatile organic compounds (VOCs) known to be related to lung disease like asthma. Its collection is non-invasive, simple to perform and therefore an attractive method for the use even in young children. We analysed breath in children of the multicenter All Age Asthma Cohort (ALLIANCE) to evaluate if "breathomics" have the potential to phenotype patients with asthma and wheeze, and to identify extrinsic risk factors for underlying disease mechanisms.
Methods
A breath sample was collected from 142 children (asthma: 51, pre-school wheezers: 55, healthy controls: 36) and analysed using gas chromatography-mass spectrometry (GC/MS)...
August 21, 2023: Journal of Breath Research
https://read.qxmd.com/read/37575259/nf%C3%AE%C2%BAb1-inhibits-memory-formation-and-supports-effector-function-of-ilc2s-in-memory-driven-asthma
#24
JOURNAL ARTICLE
Mukesh Verma, Divya Verma, Anand Santosh Sripada, Kapil Sirohi, Rangati Varma, Anita Sahu, Rafeul Alam
BACKGROUND: ILC2s are capable of generating memory. The mechanism of memory induction and memory-driven effector function (trained immunity) in ILC2s is unknown. OBJECTIVE: NFκB1 is preferentially expressed at a high level in ILC2s. We examined the role of NFkB1 in memory induction and memory-driven effector function in a mouse model of asthma. METHODS: Intranasal administration of Alternaria, flexivent, ELISA, histology, real-time PCR, western blot, flow cytometry and immunofluorescence staining...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37496871/efficacy-and-potential-positioning-of-tezepelumab-in-the-treatment-of-severe-asthma
#25
REVIEW
Vicente Plaza, Conxa Cañete, Christian Domingo, Carlos Martínez Rivera, Xavier Muñoz
The excellent results for monoclonal antibodies in the treatment of severe uncontrolled asthma (SUCA) represent a milestone in current treatment of asthmatic disorders. Remaining, however, are several subsidiary areas for improvement in which new biologics are expected to make a decisive contribution. These biologics include tezepelumab, a monoclonal antibody that blocks thymic stromal lymphopoietin (TSLP). TSLP is an epithelial-release cytokine (alarmin) that plays a key role in initiating both the innate (group 2 innate lymphoid cell (ILC) pathway) and the acquired (T helper 2 (Th2) pathway) immune responses by activating the type 2 (T2) asthma inflammatory pathway through both...
2023: Open Respir Arch
https://read.qxmd.com/read/37371472/the-functional-role-of-group-2-innate-lymphoid-cells-in-asthma
#26
REVIEW
Takahiro Matsuyama, Kentaro Machida, Keiko Mizuno, Hiromi Matsuyama, Yoichi Dotake, Masahiro Shinmura, Koichi Takagi, Hiromasa Inoue
Asthma is a heterogeneous disease characterized by chronic airway inflammation. Group 2 innate lymphoid cells (ILC2) play an important role in the pathogenesis of asthma. ILC2s lack antigen-specific receptors and respond to epithelial-derived cytokines, leading to the induction of airway eosinophilic inflammation in an antigen-independent manner. Additionally, ILC2s might be involved in the mechanism of steroid resistance. Numerous studies in both mice and humans have shown that ILC2s induce airway inflammation through inflammatory signals, including cytokines and other mediators derived from immune or non-immune cells...
May 26, 2023: Biomolecules
https://read.qxmd.com/read/37296772/blood-basophils-relevance-in-chronic-rhinosinusitis-with-aspirin-exacerbated-respiratory-disease
#27
JOURNAL ARTICLE
Giuseppe Brescia, Cristoforo Fabbris, Leonardo Calvanese, Luigia Bandolin, Barbara Pedruzzi, Valerio Maria Di Pasquale Fiasca, Silvia Marciani, Francesca Mularoni, Fabio Degli Esposti Pallotti, Michael Negrisolo, Giacomo Spinato, Anna Chiara Frigo, Gino Marioni
Aspirin-exacerbated respiratory disease (AERD) is characterized by eosinophilic asthma, chronic rhinosinusitis with nasal polyps (CRSwNP) and intolerance to cyclooxygenase-1 inhibitors. Interest is emerging in studying the role of circulating inflammatory cells in CRSwNP pathogenesis and its course, as well as their potential use for a patient-tailored approach. By releasing IL-4, basophils play a crucial role in activating the Th2-mediated response. The main aim of this study was to, first, investigate the level of the pre-operative blood basophils' values, blood basophil/lymphocyte ratio (bBLR) and blood eosinophil-to-basophil ratio (bEBR) as predictors of recurrent polyps after endoscopic sinus surgery (ESS) in AERD patients...
May 31, 2023: Diagnostics
https://read.qxmd.com/read/37289545/phospholipid-scramblase-1-regulates-innate-type-2-inflammation-in-mouse-lungs-via-crth2-dependent-mechanisms
#28
JOURNAL ARTICLE
Ashley Hernandez-Gutierrez, Sonoor Majid, Adam Eberle, Ashley Choi, Parand Sorkhdini, Dongqin Yang, Alina Xiaoyu Yang, Carmelissa Norbrun, Chuan Hua He, Chang-Min Lee, Chun Geun Lee, Jack A Elias, Yang Zhou
Exaggerated Type 2 immune responses play critical roles in the pathogenesis of a variety of diseases including asthma, allergy, and pulmonary fibrosis. Recent studies have highlighted the importance of innate type 2 immune responses and innate lymphoid 2 cells (ILC2s) in these disorders. However, the mechanisms that control the development of pulmonary innate type 2 responses (IT2IR) and the recruitment and/or activation of ILC2 cells are poorly understood. In mouse models of pulmonary IT2IR, we demonstrated that phospholipid scramblase-1 (PLSCR1), a type II transmembrane protein that mediates bidirectional and nonspecific translocation of phospholipids between the inner and outer leaflets of the plasma membrane, was a critical regulator of IT2IR in the lung...
August 1, 2023: Journal of Clinical Investigation
https://read.qxmd.com/read/37240477/pathobiology-of-type-2-inflammation-in-asthma-and-nasal-polyposis
#29
REVIEW
Corrado Pelaia, Giulia Pelaia, Angelantonio Maglio, Caterina Tinello, Luca Gallelli, Nicola Lombardo, Rosa Terracciano, Alessandro Vatrella
Asthma and nasal polyposis often coexist and are frequently intertwined by tight pathogenic links, mainly consisting of the cellular and molecular pathways underpinning type 2 airway inflammation. The latter is characterized by a structural and functional impairment of the epithelial barrier, associated with the eosinophilic infiltration of both the lower and upper airways, which can be driven by either allergic or non-allergic mechanisms. Type 2 inflammatory changes are predominantly due to the biological actions exerted by interleukins 4 (IL-4), 13 (IL-13), and 5 (IL-5), produced by T helper 2 (Th2) lymphocytes and group 2 innate lymphoid cells (ILC2)...
May 9, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/37119678/inhibition-of-non-receptor-tyrosine-kinase-lck-partially-mitigates-mixed-granulocytic-airway-inflammation-in-a-murine-model-of-asthma
#30
JOURNAL ARTICLE
Saleh A Alqarni, Sheikh F Ahmad, Faleh Alqahtani, Naif O Al-Harbi, Samiyah Alshehri, Khalid E Ibrahim, Ali S Alfardan, Sabry M Attia, Ahmed Nadeem
Asthma affects millions of people worldwide and is one of the most common inflammatory airway diseases. Asthma phenotypes are quite complex and categorized as eosinophilic, mixed granulocytic (presence of both eosinophils and neutrophils in the airways) and neutrophilic. Mixed granulocytic asthma requires large doses of inhaled corticosteroids, which are often insufficient in controlling airway inflammation. Therefore, there is a medical need to test newer therapies to control granulocytic inflammation. Lymphocyte specific protein tyrosine kinase (LCK) signaling has gained momentum in recent years as a molecular target in inflammatory diseases such as asthma...
April 26, 2023: International Immunopharmacology
https://read.qxmd.com/read/37052152/clinical-relevance-and-therapeutic-potential-of-il-38-in-immune-and-non-immune-related-disorders
#31
REVIEW
Mohammad Reza Haghshenas, Mina Roshan Zamir, Mahboubeh Sadeghi, Mohammad Javad Fattahi, Kimia Mirshekari, Abbas Ghaderi
Interleukin-38 (IL-38) is the most recent member of the IL-1 family that acts as a natural inflammatory inhibitor by binding to cognate receptors, particularly the IL-36 receptor. In vitro, animal and human studies on autoimmune, metabolic, cardiovascular and allergic diseases, as well sepsis and respiratory viral infections, have shown that IL-38 exerts an anti-inflammatory activity by modulating the generation and function of inflammatory cytokines (e.g. IL-6, IL-8, IL-17 and IL-36) and regulating dendritic cells, M2 macrophages and regulatory T cells (Tregs)...
September 1, 2022: European Cytokine Network
https://read.qxmd.com/read/36924610/hmgb1-is-a-promising-therapeutic-target-for-asthma
#32
REVIEW
Yue Zhao, Ruiting Li
High-mobility group box protein 1 (HMGB1) is a non-histone deoxyribonucleic acid-binding nuclear protein. In physiological state it is involved in gene transctioripn regulation and cell replication, differentiation and maturation. HMGB1 is actively secreted into the extracellular space in the form of intracellular vesicles, upon stimulation of inflammation and infection, by monocytes, macrophages, dendritic cells (DCs), and other immune cells, and can also be passively released by necrotic or injured cells...
March 14, 2023: Cytokine
https://read.qxmd.com/read/36835081/blood-based-biomarkers-for-eosinophilic-esophagitis-and-concomitant-atopic-diseases-a-look-into-the-potential-of-extracellular-vesicles
#33
REVIEW
Elena Grueso-Navarro, Pilar Navarro, Emilio J Laserna-Mendieta, Alfredo J Lucendo, Laura Arias-González
Eosinophilic esophagitis (EoE) is a chronic, Th2-inflammatory disease of the esophagus that can severely affect food intake. Currently, diagnosis and assessing response to treatment of EoE is highly invasive and requires endoscopy with esophageal biopsies. Finding non-invasive and accurate biomarkers is important for improving patient well-being. Unfortunately, EoE is usually accompanied by other atopies, which make it difficult to identify specific biomarkers. Providing an update of circulating EoE biomarkers and concomitant atopies is therefore timely...
February 11, 2023: International Journal of Molecular Sciences
https://read.qxmd.com/read/36820309/specific-immunoglobulin-g4-correlates-with-th2-cytokine-reduction-in-patients-with-allergic-asthma-treated-by-dermatophagoides-pteronyssinus-subcutaneous-immunotherapy
#34
JOURNAL ARTICLE
Qiujuan Su, Nina Ren, Mulin Feng, Xueni Zeng, Yan Dong, Mo Xian, Xu Shi, Tian Luo, Gang Liu, Jing Li
BACKGROUND: The modulations of lymphocyte subsets and cytokine production due to subcutaneous allergen immunotherapy (SCIT) are not fully clarified. OBJECTIVE: We investigated the changes in T-lymphocyte subsets and serum Dermatophagoides pteronyssinus -specific immunoglobulin G4 (Der-p sIgG4), as well as cytokine production during Der-p SCIT, in patients with allergic asthma. METHODS: This study involved 20 patients with allergic asthma who were receiving 156-week Der-p SCIT and 20 patients without SCIT (non-SCIT)...
January 2023: World Allergy Organization Journal
https://read.qxmd.com/read/36753412/neutrophilia-in-severe-asthma-is-reduced-in-ormdl3-overexpressing-mice
#35
JOURNAL ARTICLE
Briana N James, Cynthia Weigel, Christopher D Green, Ryan D R Brown, Elisa N D Palladino, Anuj Tharakan, Sheldon Milstien, Richard L Proia, Rebecca K Martin, Sarah Spiegel
Genome-wide association studies have linked the ORM (yeast)-like protein isoform 3 (ORMDL3) to asthma severity. Although ORMDL3 is a member of a family that negatively regulates serine palmitoyltransferase (SPT) and thus biosynthesis of sphingolipids, it is still unclear whether ORMDL3 and altered sphingolipid synthesis are causally related to non-Th2 severe asthma associated with a predominant neutrophil inflammation and high interleukin-17 (IL-17) levels. Here, we examined the effects of ORMDL3 overexpression in a preclinical mouse model of allergic lung inflammation that is predominantly neutrophilic and recapitulates many of the clinical features of severe human asthma...
March 2023: FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology
https://read.qxmd.com/read/36720753/c-type-lectin-receptor-mediated-modulation-of-t2-immune-responses-to-allergens
#36
REVIEW
Alba Angelina, Leticia Martín-Cruz, Andrés de la Rocha-Muñoz, Begoña Lavín-Plaza, Oscar Palomares
PURPOSE OF REVIEW: Allergic diseases represent a major health problem of increasing prevalence worldwide. In allergy, dendritic cells (DCs) contribute to both the pathophysiology and the induction of healthy immune responses to the allergens. Different studies have reported that some common allergens contain glycans in their structure. C-type lectin receptors (CLRs) expressed by DCs recognize carbohydrate structures and are crucial in allergen uptake, presentation, and polarization of T cell responses...
February 1, 2023: Current Allergy and Asthma Reports
https://read.qxmd.com/read/36645975/apigenin-ameliorates-non-eosinophilic-inflammation-dysregulated-immune-homeostasis-and-mitochondria-mediated-airway-epithelial-cell-apoptosis-in-chronic-obese-asthma-via-the-ros-ask1-mapk-pathway
#37
JOURNAL ARTICLE
Hang Yu, Xi Huang, Hua-He Zhu, Na Wang, Cong Xie, Yao-Long Zhou, Han-Lin Shi, Meng-Meng Chen, Yue-Ren Wu, Zhen-Hui Ruan, Yu-Bao Lyu, Qing-Li Luo, Jing-Cheng Dong
BACKGROUND: Obese asthma is one of the important asthma phenotypes that have received wide attention in recent years. Excessive oxidative stress and different inflammatory endotypes may be important reasons for the complex symptoms, frequent aggravation, and resistance to traditional treatments of obese asthma. Apigenin (API), is a flavonoid natural small molecule compound with good anti-inflammatory and antioxidant activity in various diseases and proved to have the potential efficacy to combat obese asthma...
January 6, 2023: Phytomedicine
https://read.qxmd.com/read/36572876/gene-network-analysis-for-identification-of-microrna-biomarkers-for-asthma
#38
JOURNAL ARTICLE
Paulene Cay, Cherie A Singer, Mariam A Ba
BACKGROUND: To date, reliable biomarkers for asthma have not been identified. MicroRNAs (miRNAs) are small, non-coding RNAs that negatively regulate post-transcriptional gene expression, and they are involved in various diseases, including asthma. MiRNAs may serve as ideal biomarkers due to their ability to regulate multiple pathways. This study aims to identify miRNA biomarker signatures for asthma. METHODS: We used the house dust mite (HDM) mouse model of allergic inflammation...
December 26, 2022: Respiratory Research
https://read.qxmd.com/read/36523782/profile-of-coronavirus-disease-enlightened-asthma-as-a-protective-factor-against-death-an-epidemiology-study-from-brazil-during-the-pandemic
#39
JOURNAL ARTICLE
Nathalia Mariana Santos Sansone, Felipe Eduardo Valencise, Rafael Fumachi Bredariol, Andressa Oliveira Peixoto, Fernando Augusto Lima Marson
INTRODUCTION: The possibility that asthma is not a risk factor for the worst outcomes due to coronavirus disease (COVID-19) is encouraged. The increase in Th2 response dominance can downregulate the late phase of hyperinflammation, which is typically the hallmark of more severe respiratory viral infections, alongside lower angiotensin-converting enzyme receptors in patients with asthma due to chronic inflammation. Few studies associated asthma diagnosis and COVID-19 outcomes. In this context, we aimed to associate the asthma phenotype with the clinical signs, disease progression, and outcomes in patients with COVID-19...
2022: Frontiers in Medicine
https://read.qxmd.com/read/36458743/role-of-il-22-in-acute-asthma-mouse-model
#40
JOURNAL ARTICLE
Kyu Yean Kim, Jung Hur, Hwa Young Lee, Sook Young Lee
Allergic asthma is often associated with eosinophilic inflammation, which is related to the T-helper cell type 2 (Th2) cytokines and responsive to corticosteroids. However, there are also phenotypes of non-Th2-mediated asthma, which have poor responsivity to corticosteroids. The leading phenotype of non-Th2-mediated asthma is neutrophilic asthma, which is considered difficult to treat. Recently, IL-22 has been found to be involved in neutrophilic inflammation in asthma. However, studies on the role of IL-22 in asthma are still controversial as IL-22 has both pro-inflammatory and anti-inflammatory roles in asthma...
December 2, 2022: Journal of Asthma
keyword
keyword
43776
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.